Disparities according to race, geographic location, socioeconomic status seen for telehealth use among patients initiating cancer treatment
TUESDAY, June 7, 2022 (HealthDay News) — Racial, geographic, and socioeconomic disparities were seen in telehealth use among patients initiating cancer treatment during the COVID-19 pandemic, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from June 3 to 7 in Chicago.
Jenny Guadamuz, Ph.D., from the University of Southern California in Los Angeles, and colleagues assessed demographic and socioeconomic factors associated with telemedicine use among patients initiating treatment for 21 common cancers at community oncology clinics. The national Flatiron Health deidentified database was used to identify 24,164 adult cancer patients who initiated first-line cancer treatment between March 2020 and September 2021 with follow-up through December 2021.
The researchers found that Black patients were less likely to use telemedicine services than White patients. Telemedicine use was also lower among patients without documented insurance versus patients with commercial and Medicare insurance. Compared with patients in urban areas, those in rural and suburban areas were less likely to use telemedicine services. Patients living in the least affluent areas had lower telemedicine use than those in the most affluent areas.
“Telemedicine can improve access to timely cancer care, but as this study points out, telemedicine must be available equitably, so that every patient can access the care they need and deserve,” Everett E. Vokes, M.D., president of ASCO, said in a statement.
Hospital Outcomes Better When Patients Treated by Female Physicians
More Than 1 in 4 Americans Misrepresent Symptoms to Get Antibiotics
Obesity Linked to Early-Onset Cancer Risk in Young Adults
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions